FRANKLIN RESOURCES INC

Position in MDXG — Mimedx Group, Inc.

CIK 38777 San Mateo, CA

Position in MDXG

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$679,449

-$4,128,305 QoQ

Shares Held

172,013

-75.8% QoQ

Ownership

0.115%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 98.24896955462668.ToString("F0")% Shared 0.ToString("F0")% None 1.751030445373315.ToString("F0")%

Healthcare · as of Mar 31, 2026

FRANKLIN RESOURCES INC holds $7,057,408,835 across 166 Biotechnology names. MDXG ranks #130 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	2,722,071	$2,103,180,930
2	ASND	Ascendis Pharma A/S	2,051,948	$469,342,063
3	INSM	INSMED Inc	2,617,251	$427,972,880
4	JAZZ	Jazz Pharmaceuticals plc	1,958,940	$370,337,604
5	VRTX	Vertex Pharmaceuticals Inc / Ma	551,132	$246,102,477
6	BBIO	BridgeBio Pharma, Inc.	2,438,925	$181,114,568
7	ARGX	Argenx SE	233,493	$170,508,261
8	ALNY	Alnylam Pharmaceuticals, Inc.	470,390	$155,637,935

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$679,449	172,013	-75.8%	Shares	Defined	2026-05-13
2025-12-31	$4,807,754	710,156	-5.5%	Shares	Defined	2026-02-11
2025-09-30	$5,244,261	751,327	+22.1%	Shares	Defined	2025-11-13
2025-06-30	$3,760,397	615,450	+12.3%	Shares	Defined	2025-08-12
2025-03-31	$4,163,263	547,798	-8.1%	Shares	Defined	2025-05-13
2024-12-31	$5,733,634	596,012	-0.7%	Shares	Defined	2025-02-12
2024-09-30	$3,546,070	600,012	-3.0%	Shares	Defined	2024-11-27
2024-06-30	$4,287,555	618,695	+6.6%	Shares	Defined	2024-08-14
2024-03-31	$4,470,110	580,534	+748.4%	Shares	Defined	2024-05-13
2023-12-31	$600,068	68,423	+0.5%	Shares	Defined	2024-02-09
2023-09-30	$496,506	68,108	+17.2%	Shares	Defined	2023-11-13
2023-06-30	$383,961	58,088	—	Shares	Defined	2023-08-11
No filing history on record for this holder in this stock.